Inhibitor Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INTI research report →
About the company
Inhibitor Therapeutics, Inc. , established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions.
- CEO
- Francis E. O'Donnell Jr.
- IPO
- 2013
- Employees
- 3
- HQ
- Tampa, FL, US
Price Chart
- Market Cap
- $13.63M
- P/E
- -4.07
- P/S
- 0.00
- P/B
- -6.89
- EV/EBITDA
- -3.63
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 525.87%
- ROIC
- -319.23%
- Revenue
- $0 · 0.00%
- Net Income
- $-3,300,337 · 1.16%
- EPS
- $-0.02 · 1.55%
- Op Income
- $-3,426,653
- FCF YoY
- 0.05%
- 52W High
- $0.12
- 52W Low
- $0.04
- 50D MA
- $0.08
- 200D MA
- $0.07
- Beta
- -0.78
- Avg Volume
- 10.60K
Get TickerSpark's AI analysis on INTI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 4, 26 | Jerman Michael Allen | other | 50,000 |
| May 5, 26 | Vasisht Niraj | other | 50,000 |
| Apr 1, 25 | Vasisht Niraj | other | 50,000 |
| Apr 1, 25 | Yanez Michelle | other | 50,000 |
| Apr 1, 25 | SEARS SAMUEL P JR | other | 50,000 |
| Apr 1, 25 | OSMAN RONALD E | other | 50,000 |
| Apr 1, 25 | Jerman Michael Allen | other | 50,000 |
| Dec 31, 24 | MCNULTY JAMES A | other | 0 |
| Dec 31, 24 | Yanez Michelle | other | 0 |
| Apr 1, 24 | Yanez Michelle | other | 50,000 |
Our INTI coverage
Recent articles, reports, and earnings notes.
No research on INTI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate INTI report →Similar companies
Peers in the same neighborhood.